Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Sanofi's dual-action biotech asthma drug performs well in test
Yahoo/Reuters
Tuesday, November 11, 2014 - 8:57am
tags:
Sanofi, asthma, dupilumab, Regeneron
Arrowhead CEO: We feel 'great' about our hepatitis B drug
CNBC
Monday, November 10, 2014 - 7:28pm
tags:
Arrowhead Research, hepatitis B, ARC-520
Orexigen Therapeutics (OREX) Stock Continues to Rise as EU Reviews Contrave Drug
TheStreet.com
Monday, November 10, 2014 - 4:08pm
tags:
Orexigen, Contrave, Europe
Achillion Pharma rises on results from study combining hepatitis C drugs ACH-3102 and Sovaldi
Yahoo/AP
Monday, November 10, 2014 - 3:55pm
tags:
Achillion, ACH-3102, hepatitis C, Sovaldi
Merck expects no writedowns for Zetia, Vytorin cholesterol drugs
Yahoo/Reuters
Monday, November 10, 2014 - 3:53pm
tags:
Merck, Zetia, Vytorin
Merck, Dendreon miss out on health-care rally
Marketwatch
Monday, November 10, 2014 - 3:51pm
tags:
Merck, Dendreon
Sanofi SA (SNY) Stock On A Decline Since Ousting Of CEO Chris Viehbacher
Bidness Etc.
Monday, November 10, 2014 - 11:16am
tags:
Sanofi, Chris Viehbacher
Battered ArQule shares bump up on badly needed positive data for tivantinib
Fierce Biotech
Monday, November 10, 2014 - 11:13am
tags:
Arqule, tivantinib, metastatic prostate cancer
WSJ: Salix inventory issues helped scuttle Allergan buyout
Fierce Pharma
Monday, November 10, 2014 - 11:12am
tags:
Salix, Allergan, M&A
FDA Accepts Amgen's Biologics License Application For LDL Cholesterol-Lowering Medication Evolocumab
Yahoo
Monday, November 10, 2014 - 11:05am
tags:
FDA, Amgen, evolocumab
Alexion Pharma co-founder Squinto to retire
Yahoo/AP
Monday, November 10, 2014 - 11:03am
tags:
Alexion
Justice Department Probes Generic Competition After Price Hike Reports
WSJ Pharmalot
Monday, November 10, 2014 - 11:00am
tags:
DOJ, generics, Impax Laboratories, Lannett
Ebola Contracts Worth $2 Billion Could Benefit Drugmakers
Bloomberg
Monday, November 10, 2014 - 10:58am
tags:
ebola virus, JNJ, GSK
Is this MannKind Corporation's Worst Nightmare?
Motley Fool
Monday, November 10, 2014 - 9:46am
tags:
MannKind, Afrezza, diabetes, reimbursement
Class I recall for Covidien's Puritan 980 ventilator
Mass Device
Monday, November 10, 2014 - 9:14am
tags:
Covidien, devices, recalls, Puritan 980
Curis misses Street 3Q forecasts
Yahoo/AP
Monday, November 10, 2014 - 9:09am
tags:
Curis, earnings
The Inaccurate And Unfair WHO Attack On Pharma Ebola Efforts
Forbes
Monday, November 10, 2014 - 9:03am
tags:
WHO, ebola virus, JNJ
Inovio posts 3Q loss
Yahoo/AP
Monday, November 10, 2014 - 8:16am
tags:
Inovio, earnings
Orexigen beats 3Q profit forecasts
Yahoo/AP
Monday, November 10, 2014 - 8:12am
tags:
Orexigen, earnings
Severe Epileptic Patients in Coma Respond to Sage Therapeutics Experimental Drug
TheStreet.com
Monday, November 10, 2014 - 8:11am
tags:
epilepsy, SAGE Therapeutics, SAGE-547

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.